Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > February Presentation

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Feb 27, 2023 1:45pm

126 Views

Post# 35307593

RE:February Presentation

$ 250M EBITDA at 40% market penetration, with no competitors in NA, while existing treatments lack efficacy (and in many ways is declining quickly - example antibiotic resistant infections)

Using SPectral's numbers and applyiing some basic, commonly used math....

10X EBITDA (conservatve) = $ 2.500 B

divided by 330 Million Share o/s (post latest financing)

EV/sh = $ 7.57 USD

= $ 10.28 CAD $* (using 1.3571)

* no value assumed for EAA world-wide and iDialco

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?